Smith & Nephew plc
SN
Rank in Stocks
#1669
Smith & Nephew plc, along with its subsidiaries, operates globally as a... Smith & Nephew plc, along with its subsidiaries, operates globally as a developer, manufacturer, marketer, and seller of medical technology. Its orthopaedic division offers knee implants for replacement procedures and hip implants for joint reconstruction. This segment also provides trauma and extremities products, including internal and external fixation devices crucial for stabilizing severe fractures and correcting deformities. In the sports medicine field, the company furnishes surgeons with comprehensive joint repair solutions. These encompass specialized instruments, advanced technologies, and implants necessary for minimally invasive joint surgeries, addressing soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. Additionally, its arthroscopic enabling technologies support surgical visualization and intervention inside joints, comprising fluid management equipment, high-definition cameras, digital image capture systems, scopes, light sources, and monitors. It also supplies radiofrequency, electromechanical, and mechanical tissue resection devices, along with hand instruments for removing damaged tissue, and provides ear, nose, and throat (ENT) solutions. Furthermore, Smith & Nephew delivers sophisticated advanced wound management solutions. This category features products for the treatment and prevention of acute and chronic wounds, including leg, diabetic, and pressure ulcers, burns, and post-operative wounds. Its offerings extend to advanced wound bioactives, incorporating biologics and other active technologies for debridement, dermal repair, and regeneration, as well as regenerative medicine products like skin, bone graft, and articular cartilage substitutes. The advanced wound devices portfolio includes traditional and single-use negative pressure wound therapy systems, alongside hydrosurgery devices. Primarily serving healthcare providers, Smith & Nephew plc was founded in 1856 and maintains its corporate headquarters in Watford, United Kingdom.
Share Price
$15.33
Last synced: 2026-11-09
Market Cap
$12.83B
Change (1 day)
-1.18%
Change (1 year)
-7.97%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Smith & Nephew plc (SN)
Category
Healthcare
Operating Margin for Smith & Nephew plc (SN)
Operating Margin as of November 2026 TTM: 16.69%
According to Smith & Nephew plc's latest financial reports, its current operating margin (TTM) is 16.69%. At the end of 2025 the company had an operating margin of 16.27%.
Operating Margin history for Smith & Nephew plc from 2000 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 16.69% | 2.58% |
| 2025 | 16.27% | 43.85% |
| 2024 | 11.31% | 47.65% |
| 2023 | 7.66% | 26.82% |
| 2022 | 6.04% | -46.92% |
| 2021 | 11.38% | 75.89% |
| 2020 | 6.47% | -59.21% |
| 2019 | 15.86% | -9.89% |
| 2018 | 17.60% | -10.20% |
| 2017 | 19.60% | 14.22% |
| 2016 | 17.16% | 26.64% |
| 2015 | 13.55% | -16.46% |
| 2014 | 16.22% | -12.89% |
| 2013 | 18.62% | -8.95% |
| 2012 | 20.45% | 1.29% |
| 2011 | 20.19% | -13.05% |
| 2010 | 23.22% | 21.13% |
| 2009 | 19.17% | 15.69% |
| 2008 | 16.57% | 13.26% |
| 2007 | 14.63% | -24.28% |
| 2006 | 19.32% | 16.81% |
| 2005 | 16.54% | 24.92% |
| 2004 | 13.24% | -13.18% |
| 2003 | 15.25% | 12.30% |
| 2002 | 13.58% | -5.30% |
| 2001 | 14.34% | 13.18% |
| 2000 | 12.67% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 15.24% | -99.09% |
US
|
|
| 18.08% | -98.92% |
IE
|
|
| 21.25% | -98.73% |
US
|
|
| 21.05% | -98.74% |
US
|
|
| 28.09% | -98.32% |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Smith & Nephew plc's operating margin
What is Smith & Nephew plc's operating margin?
Smith & Nephew plc's operating margin is 16.69%, as of Nov 2026.
What was Smith & Nephew plc's operating margin in 2025?
In 2025, Smith & Nephew plc's operating margin was 16.27%, compared with 11.31% in 2024.
How has Smith & Nephew plc's operating margin changed since 2020?
From 2020 to 2025, Smith & Nephew plc's operating margin was highest in 2025 (16.27%) and lowest in 2022 (6.04%).
How does Smith & Nephew plc's operating margin compare with similar companies?
Smith & Nephew plc's operating margin (16.69%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Edwards Lifesciences Corporation, with 28.09%.